{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T15:20:50Z","timestamp":1792855250623,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,31]],"date-time":"2024-08-31T00:00:00Z","timestamp":1725062400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,31]],"date-time":"2024-08-31T00:00:00Z","timestamp":1725062400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"DOI":"10.1007\/s10792-024-03270-y","type":"journal-article","created":{"date-parts":[[2024,8,31]],"date-time":"2024-08-31T02:02:01Z","timestamp":1725069721000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["The antibiotic resistance profiles of Pseudomonas aeruginosa in the Asia Cornea Society Infectious Keratitis Study"],"prefix":"10.1007","volume":"44","author":[{"given":"Wei-Boon","family":"Khor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajamani","family":"Lakshminarayanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercy Halleluyah","family":"Periayah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkatesh N.","family":"Prajna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashant","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Namrata","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jodhbir S.","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvin","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panida","family":"Goseyarakwong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vilavun","family":"Puangsricharern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai Ling","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger W.","family":"Beuerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald Tiang-Hwee","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the ACSIKS GROUP","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,31]]},"reference":[{"issue":"11","key":"3270_CR1","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.ajo.2018.07.040","volume":"195","author":"WB Khor","year":"2018","unstructured":"Khor WB, Prajna VN, Garg P et al (2018) The Asia Cornea Society Infectious Keratitis Study: a prospective multicenter study of infectious keratitis in Asia. Am J Ophthalmol 195(11):161\u2013170. https:\/\/doi.org\/10.1016\/j.ajo.2018.07.040","journal-title":"Am J Ophthalmol"},{"issue":"9","key":"3270_CR2","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.ajo.2021.03.005","volume":"229","author":"F Stapleton","year":"2021","unstructured":"Stapleton F, Lim CHL, Kweon S, Tan D, Mehta JS, ACSIKS group (2021) Cosmetic contact lens-related corneal infections in Asia. Am J Ophthalmol 229(9):176\u2013183. https:\/\/doi.org\/10.1016\/j.ajo.2021.03.005","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"3270_CR3","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.survophthal.2018.12.003","volume":"64","author":"L Ung","year":"2019","unstructured":"Ung L, Bispo PJM, Shanbhag SS, Gilmore MS, Chodosh J (2019) The persistent dilemma of microbial keratitis: global burden, diagnosis, and antimicrobial resistance. Surv Ophthalmol 64(3):255\u2013271. https:\/\/doi.org\/10.1016\/j.survophthal.2018.12.003","journal-title":"Surv Ophthalmol"},{"issue":"1","key":"3270_CR4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1099\/jmm.0.001110","volume":"69","author":"Y Hilliam","year":"2020","unstructured":"Hilliam Y, Kaye S, Winstanley C (2020) Pseudomonas aeruginosa and microbial keratitis. J Med Microbiol 69(1):3\u201313. https:\/\/doi.org\/10.1099\/jmm.0.001110","journal-title":"J Med Microbiol"},{"issue":"9","key":"3270_CR5","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1097\/OPX.0000000000001768","volume":"98","author":"RK Thomas","year":"2021","unstructured":"Thomas RK, Melton R, Vollmer PM, Asbell PA (2021) In vitro antibiotic resistance among bacteria from the cornea in the antibiotic resistance monitoring in ocular microorganisms surveillance study. Optom Vis Sci 98(9):1113\u20131121. https:\/\/doi.org\/10.1097\/OPX.0000000000001768","journal-title":"Optom Vis Sci"},{"issue":"10","key":"3270_CR6","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1016\/j.ophtha.2015.06.007","volume":"122","author":"J Vazirani","year":"2015","unstructured":"Vazirani J, Wurity S, Ali MH (2015) Multidrug-resistant Pseudomonas aeruginosa keratitis: risk factors, clinical characteristics, and outcomes. Ophthalmology 122(10):2110\u20132114. https:\/\/doi.org\/10.1016\/j.ophtha.2015.06.007","journal-title":"Ophthalmology"},{"issue":"2","key":"3270_CR7","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s00417-015-3208-7","volume":"254","author":"M Fernandes","year":"2016","unstructured":"Fernandes M, Vira D, Medikonda R, Kumar N (2016) Extensively and pan-drug resistant Pseudomonas aeruginosa keratitis: clinical features, risk factors, and outcome. Graefes Arch Clin Exp Ophthalmol 254(2):315\u2013322. https:\/\/doi.org\/10.1007\/s00417-015-3208-7","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"9","key":"3270_CR8","doi-asserted-by":"publisher","first-page":"600","DOI":"10.3390\/antibiotics9090600","volume":"9","author":"M Khan","year":"2020","unstructured":"Khan M, Stapleton F, Summers S, Rice SA, Willcox MDP (2020) Antibiotic resistance characteristics of pseudomonas aeruginosa isolated from keratitis in Australia and India. Antibiotics (Basel) 9(9):600. https:\/\/doi.org\/10.3390\/antibiotics9090600","journal-title":"Antibiotics (Basel)"},{"key":"3270_CR9","unstructured":"Performance standards for antimicrobial susceptibility testing. 30th ed. CLSI supplement M100. Wayne, PA: Clinical and Laboratory Standard Institute; 2020."},{"key":"3270_CR10","unstructured":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; Approved Standard. 7th Edition, CLSI Document M7-A7. Clinical and Laboratory Standards Institute; 2006."},{"issue":"5","key":"3270_CR11","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1167\/tvst.11.5.26","volume":"11","author":"JA Mei","year":"2022","unstructured":"Mei JA, Johnson W, Kinn B et al (2022) Antimicrobial activity of a triple antibiotic combination toward ocular Pseudomonas aeruginosa clinical isolates. Transl Vis Sci Technol 11(5):26. https:\/\/doi.org\/10.1167\/tvst.11.5.26","journal-title":"Transl Vis Sci Technol"},{"issue":"3","key":"3270_CR12","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"AP Magiorakos","year":"2012","unstructured":"Magiorakos AP, Srinivasan A, Carey RB et al (2012) Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 18(3):268\u2013281. https:\/\/doi.org\/10.1111\/j.1469-0691.2011.03570.x","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"3270_CR13","doi-asserted-by":"publisher","first-page":"P1","DOI":"10.1016\/j.ophtha.2018.10.018","volume":"126","author":"A Lin","year":"2019","unstructured":"Lin A, Rhee MK, Akpek EK et al (2019) American Academy of ophthalmology preferred practice pattern cornea and external disease panel. Bacterial keratitis preferred practice pattern. Ophthalmology 126(1):P1\u2013P55. https:\/\/doi.org\/10.1016\/j.ophtha.2018.10.018","journal-title":"Ophthalmology"},{"issue":"5","key":"3270_CR14","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1111\/ceo.14113","volume":"50","author":"M Cabrera-Aguas","year":"2022","unstructured":"Cabrera-Aguas M, Khoo P, Watson SL (2022) Infectious keratitis: a review. Clin Exp Ophthalmol 50(5):543\u2013562. https:\/\/doi.org\/10.1111\/ceo.14113","journal-title":"Clin Exp Ophthalmol"},{"issue":"11","key":"3270_CR15","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1016\/s0161-6420(96)30416-8","volume":"103","author":"RA Hyndiuk","year":"1996","unstructured":"Hyndiuk RA, Eiferman RA, Caldwell DR et al (1996) Comparison of ciprofloxacin ophthalmic solution 0.3% to fortified tobramycin-cefazolin in treating bacterial corneal ulcers. Ciprofloxacin Bacterial Keratitis Study Group. Ophthalmology 103(11):1854\u20131862. https:\/\/doi.org\/10.1016\/s0161-6420(96)30416-8","journal-title":"Ophthalmology"},{"issue":"9","key":"3270_CR16","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1016\/j.ophtha.2006.12.011","volume":"114","author":"M Constantinou","year":"2007","unstructured":"Constantinou M, Daniell M, Snibson GR, Vu HT, Taylor HR (2007) Clinical efficacy of moxifloxacin in the treatment of bacterial keratitis: a randomized clinical trial. Ophthalmology 114(9):1622\u20131629. https:\/\/doi.org\/10.1016\/j.ophtha.2006.12.011","journal-title":"Ophthalmology"},{"issue":"7","key":"3270_CR17","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1097\/ICO.0b013e3181ca2ba3","volume":"29","author":"VM Shah","year":"2010","unstructured":"Shah VM, Tandon R, Satpathy G et al (2010) Randomized clinical study for comparative evaluation of fourth generation fluoroquinolones with the combination of fortified antibiotics in the treatment of bacterial corneal ulcers. Cornea 29(7):751\u2013757. https:\/\/doi.org\/10.1097\/ICO.0b013e3181ca2ba3","journal-title":"Cornea"},{"issue":"1","key":"3270_CR18","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1097\/ICO.0000000000000664","volume":"35","author":"N Sharma","year":"2016","unstructured":"Sharma N, Arora T, Jain V et al (2016) Gatifloxacin 0.3% versus Fortified Tobramycin-cefazolin in treating nonperforated bacterial corneal ulcers: randomized controlled trial. Cornea 35(1):56\u201361. https:\/\/doi.org\/10.1097\/ICO.0000000000000664","journal-title":"Cornea"},{"issue":"4","key":"3270_CR19","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1097\/00055735-200408000-00007","volume":"15","author":"FS Mah","year":"2004","unstructured":"Mah FS (2004) Fourth-generation fluoroquinolones: new topical agents in the war on ocular bacterial infections. Curr Opin Ophthalmol 15(4):316\u2013320. https:\/\/doi.org\/10.1097\/00055735-200408000-00007","journal-title":"Curr Opin Ophthalmol"},{"issue":"10","key":"3270_CR20","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1093\/cid\/cis189","volume":"54","author":"P Lalitha","year":"2012","unstructured":"Lalitha P, Srinivasan M, Manikandan P et al (2012) Relationship of in vitro susceptibility to moxifloxacin and in vivo clinical outcome in bacterial keratitis. Clin Infect Dis 54(10):1381\u20131387. https:\/\/doi.org\/10.1093\/cid\/cis189","journal-title":"Clin Infect Dis"},{"issue":"3","key":"3270_CR21","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3109\/09286586.2013.790978","volume":"20","author":"CE Oldenburg","year":"2013","unstructured":"Oldenburg CE, Lalitha P, Srinivasan M et al (2013) Emerging moxifloxacin resistance in Pseudomonas aeruginosa keratitis isolates in South India. Ophthalmic Epidemiol 20(3):155\u2013158. https:\/\/doi.org\/10.3109\/09286586.2013.790978","journal-title":"Ophthalmic Epidemiol"},{"key":"3270_CR22","doi-asserted-by":"publisher","first-page":"783","DOI":"10.2147\/OPTH.S91286","volume":"2","author":"FA Bucci Jr","year":"2016","unstructured":"Bucci FA Jr, Nguimfack IT, Fluet AT (2016) Pharmacokinetics and aqueous humor penetration of levofloxacin 1.5% and moxifloxacin 0.5% in patients undergoing cataract surgery. Clin Ophthalmol 2:783\u2013789. https:\/\/doi.org\/10.2147\/OPTH.S91286","journal-title":"Clin Ophthalmol"},{"issue":"7","key":"3270_CR23","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1097\/ICO.0b013e31828d6d9e","volume":"32","author":"JL Chung","year":"2013","unstructured":"Chung JL, Lim EH, Song SW et al (2013) Comparative intraocular penetration of 4 fluoroquinolones after topical instillation. Cornea 32(7):1046\u20131051. https:\/\/doi.org\/10.1097\/ICO.0b013e31828d6d9e","journal-title":"Cornea"},{"issue":"4","key":"3270_CR24","doi-asserted-by":"publisher","first-page":"e120","DOI":"10.1111\/j.1755-3768.2010.01897.x","volume":"88","author":"RP Kowalski","year":"2010","unstructured":"Kowalski RP, Romanowski EG, Mah FS, Shanks RM, Gordon YJ (2010) Topical levofloxacin 1.5% overcomes in vitro resistance in rabbit keratitis models. Acta Ophthalmol 88(4):e120\u2013e125. https:\/\/doi.org\/10.1111\/j.1755-3768.2010.01897.x","journal-title":"Acta Ophthalmol"},{"issue":"10","key":"3270_CR25","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1089\/jop.2015.0026","volume":"31","author":"K Tajima","year":"2015","unstructured":"Tajima K, Miyake T, Koike N et al (2015) Two different concentrations of topical levofloxacin for the treatment of multidrug-resistant Pseudomonas aeruginosa keratitis. J Ocul Pharmacol Ther 31(10):636\u2013641. https:\/\/doi.org\/10.1089\/jop.2015.0026","journal-title":"J Ocul Pharmacol Ther"},{"issue":"4","key":"3270_CR26","first-page":"277","volume":"40","author":"CL Ventola","year":"2015","unstructured":"Ventola CL (2015) The antibiotic resistance crisis: part 1: causes and threats. P T 40(4):277\u2013283","journal-title":"P T"},{"issue":"3","key":"3270_CR27","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1586\/eri.13.12","volume":"11","author":"JN Pendleton","year":"2013","unstructured":"Pendleton JN, Gorman SP, Gilmore BF (2013) Clinical relevance of the ESKAPE pathogens. Expert Rev Anti Infect Ther 11(3):297\u2013308. https:\/\/doi.org\/10.1586\/eri.13.12","journal-title":"Expert Rev Anti Infect Ther"},{"key":"3270_CR28","unstructured":"World Health Organization (2017) WHO publishes list of bacteria for which new antibiotics are urgently needed [Internet]. https:\/\/www.who.int\/news\/item\/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed. Accessed 21 Aug 2023"},{"issue":"2","key":"3270_CR29","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/j.1444-0938.2010.00536.x","volume":"94","author":"MD Willcox","year":"2011","unstructured":"Willcox MD (2011) Review of resistance of ocular isolates of Pseudomonas aeruginosa and staphylococci from keratitis to ciprofloxacin, gentamicin and cephalosporins. Clin Exp Optom 94(2):161\u2013168. https:\/\/doi.org\/10.1111\/j.1444-0938.2010.00536.x","journal-title":"Clin Exp Optom"},{"issue":"2","key":"3270_CR30","doi-asserted-by":"publisher","first-page":"e150","DOI":"10.1093\/pubmed\/fdv072","volume":"38","author":"G Porter","year":"2016","unstructured":"Porter G, Grills N (2016) Medication misuse in India: a major public health issue in India. J Public Health (Oxf) 38(2):e150\u2013e157. https:\/\/doi.org\/10.1093\/pubmed\/fdv072","journal-title":"J Public Health (Oxf)"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-024-03270-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-024-03270-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-024-03270-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T11:43:04Z","timestamp":1741866184000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-024-03270-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,31]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3270"],"URL":"https:\/\/doi.org\/10.1007\/s10792-024-03270-y","relation":{},"ISSN":["1573-2630"],"issn-type":[{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,31]]},"assertion":[{"value":"4 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Wei-Boon Khor has received honorarium by Santen Pharmaceuticals for presentations; and received support by the Asia Cornea Society for meetings. Jodhbir S. Mehta and Donald TH Tan are co-inventors of the EndoGlide, and have financial interests in the device (AngioTech, Reading, Pennsylvania, USA\/Network Medical Products, North Yorkshire, UK). Ai Ling\u00a0Tan has received honorarium for lectures from the Singapore Association of Pharmaceutical Industries.  The following authors have no relevant financial or non-financial interests to disclose.: Rajamani\u00a0Lakshminarayanan, Venkatesh Prajna, Prashant Garg, Namrata Sharma, Alvin Young, Panida Goseyarakwong, Vilavun Puangsricharern, Mercy Halleluyah Periayah, Roger Beuerman.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study adhered to the tenets of the Declaration of Helsinki. Ethics review was waived for this study by the SingHealth Institutional Review Board as only bacterial isolates with no patient identifiers were provided for this laboratory study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"361"}}